المؤلفون: Dettorre, Gino M, Dafni, U., Aguilar Company, Juan, Castelo-Branco, L., Lambertini, Matteo, Cortellini, Alessio

المساهمون: Institut Català de la Salut, Cortellini A Department of Surgery & Cancer, Hammersmith Hospital Campus, Imperial College London, London, UK. Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Roma, Italy. Dettorre GM Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri, USA. Dafni U Laboratory of Biostatistics, School of Health Sciences, National and Kapodistrian University of Athens, Athens, Greece. Aguilar-Company J Servei d’Oncologia Mèdica, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Servei de Malalties Infeccioses, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Castelo-Branco L Scientific and Medical Division, ESMO (European Society for Medical Oncology), Lugano, Switzerland. NOVA National School of Publich Health, NOVA University, Lisbon, Portugal. Lambertini M Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genoa, Genova, Italy. Medical Oncology Department, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: COVID-19 (Malaltia), Immunoteràpia, Càncer - Tractament, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Biological Therapy::Immunomodulation::Immunotherapy, DISEASES::Neoplasms, Other subheadings::Other subheadings::Other subheadings::/drug therapy, DISEASES::Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::terapia biológica::inmunomodulación::inmunoterapia, ENFERMEDADES::neoplasias, Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia, ENFERMEDADES::virosis::infecciones por virus ARN::infecciones por Nidovirales::infecciones por Coronaviridae::infecciones por Coronavirus

وصف الملف: application/pdf

العلاقة: Journal for ImmunoTherapy of Cancer;10(11); http://dx.doi.org/10.1136/jitc-2022-005732Test; Cortellini A, Dettorre GM, Dafni U, Aguilar-Company J, Castelo-Branco L, Lambertini M, et al. Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: a joint analysis of OnCovid and ESMO-CoCARE registries. J Immunother Cancer. 2022 Nov;10(11):e005732.; https://hdl.handle.net/11351/8618Test

الإتاحة: https://doi.org/10.1136/jitc-2022-005732Test
https://hdl.handle.net/11351/8618Test

المؤلفون: Dettorre, Gino M, Dolly, Saoirse, Loizidou, Angela, Chester, John, Jackson, Amanda, Mukherjee, Uma, Aguilar Company, Juan, Mirallas Viñas, Oriol, García Illescas, David, Ruiz Camps, Isabel, Tabernero Caturla, Josep, Saoudi Gonzalez, Nadia

المساهمون: Institut Català de la Salut, Dettorre GM Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, UK. Dolly S Medical Oncology, Guy’s and St Thomas’ NHS Foundation Trust (GSTT), London, UK. Loizidou A Department of Infectious Diseases, Internal Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Chester J Medical Oncology, School of Medicine, Cardiff University, Cardiff, UK. Medical Oncology, Velindre Cancer Centre, Cardiff, UK. Jackson A Clinical Trials, Velindre Cancer Centre, Cardiff, UK. Mukherjee U Medical Oncology, Barts Health NHS Trust, London, UK. Aguilar-Company J Servei d’Oncologia Mèdica, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Servei de Malalties Infeccioses, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Mirallas O, Saoudi-Gonzalez N, García-Illescas D Servei d’Oncologia Mèdica, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Ruiz-Camps I Servei de Malalties Infeccioses, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Tabernero J Servei d’Oncologia Mèdica, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. IOB-Quiron, UVic-UCC, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: COVID-19 (Malaltia) - Complicacions, Càncer - Epidemiologia, Inflamació, DISEASES::Pathological Conditions, Signs and Symptoms::Pathologic Processes::Inflammation::Systemic Inflammatory Response Syndrome, DISEASES::Neoplasms, DISEASES::Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections, Other subheadings::Other subheadings::Other subheadings::/complications, ENFERMEDADES::afecciones patológicas, signos y síntomas::procesos patológicos::inflamación::síndrome de respuesta inflamatoria sistémica, ENFERMEDADES::neoplasias, ENFERMEDADES::virosis::infecciones por virus ARN::infecciones por Nidovirales::infecciones por Coronaviridae::infecciones por Coronavirus, Otros calificadores::Otros calificadores::Otros calificadores::/complicaciones

وصف الملف: application/pdf

العلاقة: Journal for ImmunoTherapy of Cancer;9(3); http://dx.doi.org/10.1136/jitc-2020-002277Test; Dettorre GM, Dolly S, Loizidou A, Chester J, Jackson A, Mukherjee U, et al. Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score. J Immunother Cancer. 2021 Mar 22;9(3):e002277.; https://hdl.handle.net/11351/6547Test; 000631879100004

الإتاحة: https://doi.org/10.1136/jitc-2020-002277Test
https://hdl.handle.net/11351/6547Test

المؤلفون: Soosaipillai, Gehan, Wu, Anjui, Dettorre, Gino M, Diamantis, Nikolaos, Chester, John, Moss, Charlotte, Aguilar Company, Juan, Ruiz Camps, Isabel, Cabirta Touzon, Alba, Tabernero Caturla, Josep, Saoudi Gonzalez, Nadia

المساهمون: Institut Català de la Salut, Soosaipillai G Cancer Division, University College London Hospitals, London, UK. Wu A Cancer Division, University College London Hospitals, London, UK UCL Cancer Institute, Fitzrovia, London, UK. Dettorre GM Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, UK. Diamantis N Medical Oncology, Barts Health NHS Trust, London, UK. Chester J Medical Oncology, School of Medicine, Cardiff University, Cardiff, UK. Medical Oncology, Velindre Cancer Centre, Cardiff, UK. Moss C Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King’s College London, London, UK. Aguilar-Company J Servei d’Oncologia Mèdica, Servei de Malalties Infeccioses, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Saoudi N, Tabernero J Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Ruiz-Camps I Servei de Malalties Infeccioses, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Cabirta A Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Càncer - Tractament, COVID-19 (Malaltia), Tractament pal·liatiu, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Patient Care::Terminal Care::Hospice Care, DISEASES::Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections, DISEASES::Neoplasms, Other subheadings::Other subheadings::/therapy, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::asistencia al paciente::asistencia en fase terminal::cuidados paliativos al final de la vida, ENFERMEDADES::virosis::infecciones por virus ARN::infecciones por Nidovirales::infecciones por Coronaviridae::infecciones por Coronavirus, ENFERMEDADES::neoplasias, Otros calificadores::Otros calificadores::/terapia

وصف الملف: application/pdf

العلاقة: Therapeutic Advances in Medical Oncology;13; https://doi.org/10.1177/17588359211042224Test; Soosaipillai G, Wu A, Dettorre GM, Diamantis N, Chester J, Moss C, et al. Specialist palliative and end-of-life care for patients with cancer and SARS-CoV-2 infection: a European perspective. Ther Adv Med Oncol. 2021 Sep 2;13:1-17.; https://hdl.handle.net/11351/7430Test; 000697410800001

الإتاحة: https://doi.org/10.1177/17588359211042224Test
https://hdl.handle.net/11351/7430Test